Meanwhile, we used multivariate analysis to suggest that NAFLD, CEA, CA19-9, and LN status were associated with an increased incidence of synchronous liver metastasis in CRC patients. The gene discussed is CEACAM5; the disease is metabolic dysfunction-associated steatotic liver disease.